About this Journal Submit a Manuscript Table of Contents
Sarcoma
Volume 2014 (2014), Article ID 475067, 7 pages
http://dx.doi.org/10.1155/2014/475067
Clinical Study

High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group

1Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, 1 Place Joseph Renaut, 69008 Lyon, France
2Unit of Biostatistics, Leon Bérard Cancer Centre, University of Lyon, 69008 Lyon, France
3Department of Paediatric Haematology and Oncology, Hôpital Armand Trousseau, 75012 Paris, France
4Department of Paediatrics, Curie Institute, 75248 Paris, France
5Department of Paediatrics, Children’s Hospital, 59037 Lilles, France
6Department of Paediatrics, La Timone Hospital, 13385 Marseille, France
7Department of Paediatrics, Children’s Hospital, 54000 Nancy, France
8Department of Paediatrics, Gustave Roussy Institute, 94805 Villejuif, France

Received 12 November 2013; Accepted 15 December 2013; Published 4 February 2014

Academic Editor: Carola A. S. Arndt

Copyright © 2014 Perrine Marec-Berard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Perrine Marec-Berard, Céline Segura-Ferlay, Marie-Dominique Tabone, et al., “High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group,” Sarcoma, vol. 2014, Article ID 475067, 7 pages, 2014. doi:10.1155/2014/475067